Search Results - antonio+jimeno

1 Results

Sort By:

Combination Therapy to Treat Gemcitabine-Resistant Cancers

Unmet Need: Gemcitabine resistance is a widespread problem. A large proportion of cancer patients end up receiving gemcitabine at some point of their care (as is approved in lung, pancreatic, breast and ovarian cancer), and although efficacious in a third of the cases, most do not respond, and even those who respond eventually develop resistance. Plk1...

Published: 3/13/2025 | Inventor(s): Manuel Hidalgo, Antonio Jimeno

Keywords(s): Cancers, Cell Therapy/Targeted Therapy, Combination, Disease Indication, Therapeutic Matter, Therapeutics, Therapy Type

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Cell Therapies, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Therapeutic Modalities